Tumor necrosis factor-&#945; inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study.

Rousset, Laurie; de Masson, Adèle; Begon, Edouard; Villani, Axel; Battistella, Maxime; Rybojad, Michel; Jachiet, Marie; Bagot, Martine; Bouaziz, Jean-David; Lepelletier, Clémence

Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study.

Rousset, Laurie; de Masson, Adèle; Begon, Edouard; Villani, Axel; Battistella, Maxime; Rybojad, Michel; Jachiet, Marie; Bagot, Martine; Bouaziz, Jean-David; Lepelletier, Clémence.

Afiliação

Rousset L; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
de Masson A; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Begon E; Service de Dermatologie, Centre Hospitalier René-Dubos (Pontoise), Pontoise, France.
Villani A; Service de Dermatologie, Hôpital Edouard Herriot, Hospices Civiles de Lyon, Lyon, France.
Battistella M; Service de Pathologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Rybojad M; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Jachiet M; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Bagot M; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Bouaziz JD; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France.
Lepelletier C; Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France. Electronic address: clemence.lepelletier@aphp.fr.

J Am Acad Dermatol ; 80(4): 1141-1143, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30342166

Assuntos

Fármacos Dermatológicos/uso terapêutico; Infliximab/uso terapêutico; Pioderma Gangrenoso/tratamento farmacológico; Adalimumab/uso terapêutico; Corticosteroides/uso terapêutico; Adulto; Anticorpos Monoclonais/uso terapêutico; Quimioterapia Combinada; Etanercepte/uso terapêutico; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Resultado do Tratamento; Fator de Necrose Tumoral alfa/antagonistas & inibidores; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pioderma Gangrenoso / Fármacos Dermatológicos / Infliximab Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google